Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule. (Record no. 26673486)

MARC details
000 -LEADER
fixed length control field 01459 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517130326.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201712s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1752-8062
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/cts.12433
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Nagy, C F
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20171212
245 00 - TITLE STATEMENT
Title Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical and translational science
Date of publication, distribution, etc. 01 2017
300 ## - PHYSICAL DESCRIPTION
Extent 12-19 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anthrax
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antitoxins
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Macaca fascicularis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Rabbits
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Respiratory Tract Infections
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Time Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Translational Research, Biomedical
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element United States
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element United States Food and Drug Administration
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mondick, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Serbina, N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Casey, L S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Carpenter, S E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name French, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Guttendorf, R
773 0# - HOST ITEM ENTRY
Title Clinical and translational science
Related parts vol. 10
-- no. 1
-- p. 12-19
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/cts.12433">https://doi.org/10.1111/cts.12433</a>
Public note Available from publisher's website

No items available.